BC
IMMU

Brinker Capital’s Immunomedics Inc IMMU Stock Holding History

Brinker Capital’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$2.66M Buy
75,052
+6,452
+9% +$189K 0.08% 224
2020
Q1 		$925K Sell
68,600
-1,793
-3% -$30.2K 0.04% 447
2019
Q4 		$1.49M Buy
70,393
+17,845
+34% +$315K 0.05% 391
2019
Q3 		$697K Buy
52,548
+7,677
+17% +$113K 0.02% 605
2019
Q2 		$622K Sell
44,871
-4,506
-9% -$67.8K 0.02% 624
2019
Q1 		$949K Buy
+49,377
New +$796K 0.04% 473

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Brinker Capital's IMMU Position: Q2 2020 in Review

Brinker Capital increased its Immunomedics Inc (IMMU) stake by 9.4% in Q2 2020, buying an estimated $189K and bringing the position to 75,052 shares worth $2.66M. The position accounts for 0.08% of the portfolio, ranked #224.

Brinker Capital first reported a position in IMMU in Q1 2019 and has held it in 6 quarters since. 313 funds tracked by Wall St. Rank hold IMMU as of Q2 2020.

  • Brinker Capital held 75,052 shares of Immunomedics Inc worth $2.66M as of Q2 2020.
  • Brinker Capital bought 6,452 Immunomedics Inc shares in Q2 2020, an estimated $189K.
  • Immunomedics Inc made up 0.08% of Brinker Capital's portfolio in Q2 2020, its #224 holding.
  • Brinker Capital first reported a position in Immunomedics Inc in Q1 2019 and has held it in 6 quarters since.
  • 313 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.